The production by monocytes of interleukin-la (IL-la), interleukin-1lj# ), , and tumor necrosis factor alpha (TNFa) in intensive care unit (ICU) patients with sepsis syndrome (n = 23) or noninfectious shock (n = 6) is reported. Plasma cytokines, cell-associated cytokines within freshly isolated monocytes and LPS-induced in vitro cytokine production were assessed at admission and at regular intervals during ICU stay. TNFa and IL-6 were the most frequently detected circulating cytokines. Despite the fact that IL-la is the main cytokine found within monocytes upon in vitro activation of cells from healthy individuals, it was very rarely detected within freshly isolated monocytes from septic patients, and levels of cell-associated IL-1,@ were lower than those of TNFa. Cell-associated IL-1,6 and TNFa were not correlated with corresponding levels in plasma. Upon LPS stimulation, we observed a profound decrease of in vitro IL-la production by monocytes in all patients, and of IL-1if, IL-6, and TNFa in septic patients. This reduced LPS-induced production of cytokines was most pronounced in patients with gram-negative infections. Finally, monocytes from survival patients, but not from nonsurvival ones recovered their capacity to produce normal amounts of cytokines upon LPS stimulation. In conclusion, our data indicate an in vivo activation of circulating monocytes during sepsis as well as in noninfectious shock and suggest that complex regulatory mechanisms can downregulate the production of cytokines by monocytes during severe infections.
Introduction
Cytokines are essential for hematopoiesis and immune responses, and play a key role in the defense against infectious diseases. In animal models, circulating IL-1, IL-6, and tumor necrosis factor (TNF)' have been documented after injection of whole bacteria or endotoxins prepared from gram-negative bacteria or toxins derived from gram-positive bacteria (1) (2) (3) (4) (5) (6) (7) . Similarly in human, bolus injection of LPS induces a transient 1 . Abbreviations used in this paper: ARDS, adult respiratory distress syndrome; SAPS, simplified acute physiological score; TNF, tumor necrosis factor. appearance of IL-1, TNFa, and IL-6 in plasma (8) (9) (10) . The presence ofcirculating cytokines has been often reported in the plasma of infected patients (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) . Most of the deleterious effects of microbial toxins, especially endotoxins, can be mimicked by IL- 1 and TNF. This was demonstrated in case of pulmonary injury (20, 21), adult respiratory distress syndrome (ARDS) (22, 23) , hemodynamic, and cardiovascular dysfunctions (24) (25) (26) , intravascular coagulation (27, 28) , and tissue lesions (29, 30) . IL-6, together with IL-1 and TNF, plays a major role in the production ofacute phase proteins by hepatocytes (31) (32) (33) and in fever (34, 35) . In addition, these cytokines are able to induce each other via cascade events (36) (37) (38) (39) (40) , and potentiation ofpathologic effects are observed consecutively to the synergistic action of these mediators together (41) (42) (43) (44) , or with bacterial products (45) . Levels of TNF have been associated with the severity of illness (18) and amounts of circulating TNF and IL-6 have been reported to correlate with the prognosis of the disease (10) (11) (12) (13) (17) (18) (19) . During infection, the major cytokine production is very probably consecutive to a nonspecific activation of monocytes/macrophages by microbial-derived products. The exact nature ofthe cells involved in the process leading to the presence of circulating cytokines has been poorly studied. We had previously shown in hemodialyzed patients that the presence of IL-l activity in cell lysates could reflect the in vivo monocyte activation (46) . Such an in vivo activation has also been reported by Haeffner-Cavaillon et al. (47) who observed the presence of IL-If in cell lysates from monocytes of patients undergoing cardiopulmonary bypass. Thus, in order to characterize the origin ofthe circulating cytokines, we measured IL-1, TNFa, and IL-6 production by monocytes from patients with sepsis. Because cytokines, mainly IL-1, can be accumulated within the cells, we investigated the content of freshly isolated monocytes and we studied the capacity of these cells to release in vitro these cytokines in the absence ofexogeneous stimulus as well as after endotoxin stimulation.
Methods
Patients. 29 patients admitted to the Intensive Care Unit (ICU) were studied (Table I) . 23 (15 males, 8 females; mean age±SD = 65+15; range, 32-81) fulfilled the criteria for the sepsis syndrome as described by Bone et al. (48) , including evidence ofan infectious site and a sign of inadequate organ perfusion (mental dysfunction, hypoxemia, elevated plasma lactate, oroliguria). Ofthese, 14 met the criteria for septic shock (sepsis syndrome plus a systolic BP < 90 mmHg or a decrease from baseline in systolic BP > 40 mmHg), and seven met the criteria for ARDS (bilateral alveolar infiltrates, pulmonary wedged pressure < 18 mmHg, and PaOJFiO2 < 150 with positive expiratory pressure 2 5 cm H20). The infectious conditions included pneumonia (n = 8), peritonitis (n = 4), catheter-related sepsis (n = 3), pyelonephritis (n = 2), infectious aortic aneurism (n = 1), aortic graft sepsis (n = 1), cholangitis (n = 1), cellulitis (n = 1), meningitis (n = 1), and meningococcal arthritis (n = 1). The pathogenic agents were gram-negative bacilli (GNB) in nine cases, gram-positive cocci (GPC) in seven, association of GNB and GPC in six, and Mycobacterium tuberculosis in one. 10 patients were bacteremic. The simplified acute physiologic score (49) were admitted because of cardiogenic (n = 3), hemorrhagic (n = 2), or hypovolemic shocks (n = 1). The simplified acute physiologic score on admission was 12.7±4.3. All patients with noninfectious shock (mean weight = 71±17 kg; range, 56-100) received parenteral feeding (glucids + lipids = 1,465±525 KCal/d; nitrogen = 13 g/d). Their treatment included antibiotics (n = 3), morphinics (n = 5), benzodiazepin (n = 4), cyclooxygenase inhibitors (n = 1), catecholamines (n = 3), heparin (n = 4), and insuline (n = 2). 10 patients died in the ICU. Healthy controls (n = 14) were donors ofeither sex from the blood bank and research workers from our laboratory.
Collection of blood samples. Blood was collected within 2 no no no no no no none and 0.5 ml of fresh RPMI medium were added. The plates were then frozen as previously described (52) . Three cycles of freezing-thawing were performed before harvesting the cell lysate which was then centrifuged and kept at -30'C before cytokine content assessments. In vitro cultures. In vitro cultures were performed as previously described (50, 51) . Briefly, after washing, adherent cells were cultured for 24 h in 0.5 ml RPMI-1640 medium supplemented with antibiotics, 1 Ag/ml indomethacin, and 0.2% normal human serum, in the absence (spontaneous cytokine production) or in the presence of2 s/ml Neisseria meningitidis LPS kindly provided by Dr. M. Caroff(Institut Biochimie, Orsay, France). This LPS was specially chosen for its potency to induce cytokine production (53) . At the end ofthe culture, supernatants were harvested, and cell lysates prepared as described above.
IL-6 bioassay. IL-6 activity was determined by using the specific 7TDl IL-6-dependent cell line (54) (55) . Briefly, 125 jg of tetrazolium salts (MTT) were added to each well and after 1-2 h ofincubation at 370C, the test was then stopped with 100 AI/well of an extraction buffer (20% SDS, 50% DMF in H20, 2.5% HCI 1 N, 2.5% ofan 80% acetic acid solution, pH 7.4). After an overnight incubation at 370C, the optical densities were measured at 540 nm using an automated microELISA autoreader. 1 U ofIL-6 corresponds to half-maximum growth ofthe hybridoma cells. IL-6 activity detected in supernatants of LPS-stimulated monocytes and in plasma was completely abolished by the addition of 10 1Ag rabbit polyclonal anti-human IL-6 antibodies (Genzyme Corp., Boston, MA).
TNFa RIA. The TNFa RIA was based on a competitive inhibition assay for TNFa as developed by Van der Meer et al. (56) , and modified in our laboratory. In every assay, 10 standards of TNFa (Rhone Poulenc, France) containing 0, 40, 80, 150, 300, 600, 1,250, 2,500, 5,000, and 10,000 pg/ml were employed. All standards and cell supernatant or cell lysate samples were diluted in a BSA buffer. TNFa in plasma was assessed in undiluted samples. On day 1, 100 Al ofa rabbit anti-TNFa antiserum (a kind gift of Catherine Rougeot, Institut Pasteur) diluted 1:10,000 to precipitate 35% of the radiolabeled TNF was added to 100
Al of standards or samples. To determine the nonspecific binding, 100 ,l of BSA buffer was added to a tube instead of sample. Then 300 AI of BSA buffer were added to each tube. After vortexing, the tubes were incubated for 24 h at room temperature. On day 2, 100 Ml of 125I-TNFa solution (30 ACi/Ag, New England Nuclear, Boston, MA) containing -10,000 cpm was added to each tube, and after vortexing left for a further incubation at room temperature for 24 h. On day 3, 500 j1 of BSA buffer containing 6% of polyethylene glycol 8000 (Sigma Chemical Co.), 1% ofhorse anti-rabbit IgG (C. Rougeot, Institut Pasteur) and 0.1% ofnormal rabbit serum were added. The tubes were vortexed and incubated for 1 h at room temperature. The tubes were then centrifuged at 1,500 gfor 15 min at room temperature. Thereafter, the supernatants were discarded and the tubes were kept inverted for 30 min and drained on absorbant paper. Tubes were counted in a gamma counter and the value for nonspecific binding was subtracted. All standards and samples were expressed as percentage of the standard containing no TNFa (zero standard). The concentrations of TNFa in pg/ml on the logarithmic x-axis were plotted against the binding percentage on a logarithmic -axis. The standard curve obtained was used to determine the concentrations of TNFa in samples. The detection limit was 70 pg/ml (set binding of 95% of zero standard).
IL-J# RIA. To remove putative factors present in plasma that interfere with IL-hi RIA, a chloroform extraction was performed as described by Cannon et al. (57) . 1 ml ofchloroform was transfered in 1.5 ml eppendorf tube containing 500 M of plasma. Each tube was mixed vigorously for 10 min and centrifuged at 10,000 g for 10 min at 4°C. This operation was repeated twice. The tube was left undisturbed for 20 min at room temperature. The aqueous phase was collected and stored at -300C until assaying. A similar RIA protocol as that used for TNFa measurement was employed to determine the concentration of IL,IlP. Standard IL-I,8 was obtained from Rhone Poulenc (France), rabbit anti-IL-lI antiserum diluted (1:100) was purchased from Genzyme Corp. and '25I-IL-lI (126-253 MCi/Mg) from New England Nuclear. On day 3,500 Ml ofBSA buffer containing 6% polyethylene glycol 8000, 1% ofsheep anti-rabbit IgG (Sigma Chemical Co.) and 0.05% normal rabbit serum were added to each tube. Determination of IL-1 # concentrations in plasma and samples were calculated as described above. The detection limit was 70 pg/ml.
IL-la ELISA. The IL-a concentrations were determined by a specific ELISA method developed in our laboratory using two anti-IL-la monoclonal antibodies which have been obtained in collaboration with J.-C. Mazie (Hybridolab, Institut Pasteur). After immunization of Balb/c mice with recombinant human interleukin-la (hrIL-la) kindly provided by Rhone Poulenc, spleen cells were fused with X63-Ag8.653 mouse myeloma cells (58) . Hybridoma cells were then tested for antibody production against IL-la by ELISA. Cells from positive wells were cloned by limiting dilutions in microtiter plates. Immunoglobulin subclass determinations were performed using MAb isotyping from Amersham International, Amersham, UK). Hybridomas were expanded for antibody production by intraperitoneal injection into pristane-primed mice. Two antibodies were selected: one monoclonal (28-9) is an IgGl, and the other (2-12) is an IgG2b. They do not recognize the same epitope on IL-la molecule as judged by competition ELISA and do not bind to IL-Iji. Both inhibit the biological activity ofIL-la in the thymocyte comitogenic assay.
On day 1, Luxlon ELISA microtiter plates were coated with 100 Ml of monoclonal mouse IgGl anti-rhIL-la (10 Ag/ml in carbonate buffer) and incubated 2 h at 370C. The plates were washed three times with 0.1% tween-20 PBS. Standards (0, 10, 30, 100, 300, 1,000, 3,000, and 10,000 pg/ml rhIL-la) or cell supernatant or cell lysate samples diluted in 1% BSA, 0.1% Tween-20 PBS were added to coated wells and incubated overnight at 4VC. On day 2, the plates were washed three times and 100 ul of the second monoclonal mouse anti-rhIL-la (IgG2b) (1:2,000 in BSA/Tween/PBS) were added into each well.
Plates were incubated for 3 h at 370C. After washing, 100 MI of peroxydase conjugate anti-mouse IgG2b (1:1,000) (ICN Biomedicals, Inc., Irvine, CA) were added to each well and the plates were left for 1 h at 370C. After washing, enzymatic activity was detected with a phosphate citrate buffer containing 1 mg/ml O-phenylenediamine dihydroxychloride (Sigma Chemical Co.) and hydrogen peroxyde (0.06%). The reaction was stopped with 50 Ml of HC1 3 N and the absorbance was read at 492 nm in a microplate reader (Titertek multiskan MC340; Flow Laboratories, Inc., McLean, VA). The levels of IL-la in the samples were calculated by reference to the standard curve. The detection limit of IL-la was 30 pg/ml. All cytokine measurements have been assessed using the international standards (National Institute for Biological Standards and Controls, Herfordshire, UK).
Statistical analysis. Statistical analyses were carried out using the paired or unpaired student t test.
Results
Circulating cytokines. Cytokines were under detection limits in plasma of healthy controls. The levels of plasma TNFa, IL-6, and IL-1I at admission and the maximum levels of circulating cytokines during longitudinal survey are plotted in Table II . No IL-I a could be detected. Circulating TNFa could be detected in 86% of the patients, IL-6 in 83%, and IL-1I, in only 57% of the patients. Maximum levels of TNFa and IL-If were significantly higher than the corresponding levels at admission. Significant amounts of circulating cytokines were also observed in patients with nonseptic shock. At the end of the survey, only two among 16 survival infected patients still had detectable (Fig. 3 ), IL-6 and TNFa (Fig. 4) was found in septic patients who survived. After LPS stimulation, levels close to normal or even slightly higher for IL-6 and TNFa were obtained. On the contrary, in septic patients who died, a lowered production of cytokines by monocytes upon LPS stimulation persisted until the last determination before death.
No correlation was found between the levels of cytokine produced by monocytes upon LPS stimulation and the severity score, the drugs which were used, or the nutritional status ofthe patients. 
Discussion
Significant amounts of circulating cytokines in septic patients have been well documented since 1987 (10) (11) (12) (13) (14) (15) (16) (17) (18) . In animal models half-life of i.v. injected TNFa is -6-7 min (59). A biphasic plasma clearance has been described for IL-I/ (60) and IL-6 (61) with an initial rapid disappearance of3 min and a subsequent slower one (1-4 h). In this context, the fact that cytokines might be detectable in plasma over a long period of time as demonstrated in this study (6 la) as well as in several other ones (17, 62) suggests an intensive and continuous production. The cellular origin of these circulating cytokines remains to be fully elucidated. In the literature, little information is available on cell-associated cytokines in freshly isolated monocytes. As it is well known that IL-I can be accumulated within activated monocytes, investigations have been mainly correlate with the levels of the corresponding circulating cytokines. However, it is likely that measurable circulating cytokines represent the excess of produced cytokines. One could assume that in vivo "reasonable" production would not be detected in plasma because all cytokines would be trapped by their specific high-affinity receptors on host cells. Indeed in the last determinations performed in survival patients, TNFa was often detected within freshly isolated monocytes, whereas plasma TNFa levels were back under detection limit values. Furthermore, the absence of correlation between plasma and cell-associated levels might also suggest that circulating monocytes are not the only sources of circulating cytokines and that other cells, like Kupffer cells or alveolar macrophages, could also participate to this production.
When monocytes were cultured in the absence ofany stimuli, spontaneous release of TNFa and IL-1# were not significantly higher than in controls (data not shown). In this study we have investigated the behavior of isolated monocytes to respond in vitro to an LPS-induced activation. In septic patients, we found a profound impairment of LPS-induced ILla, IL-1fI, TNFa, and IL-6 productions which were dramatically decreased. We have chosen optimal culture conditions (i.e., in the presence of indomethacin and 0.2% normal human serum) for which we established the levels of IL-la, IL-I(, TNFa, and IL-6 produced by monocytes from normal healthy donors. Among peripheral blood mononuclear cells, a rather higher number of nonspecific esterase positive (NSE+) cells was obtained in the beginning of the follow up of the septic patients. As a constant number of input NSE+ cells were cultured, a comparison between different cultures was possible. We did not observe any differences in adherence properties of monocytes from normal donors or septic patients. In the group of patients with noninfectious shock, a reduced production of IL-1a was also noticed, whereas this was not the case for IL-1 f, IL-6, and TNFa. This observation confirms the fact that the regulation of IL-1 a and IL-l 3 productions are under distinct pathways (65) . This downregulation of cytokine production was especially significant for patients with gram-negative infections. In agreement with our findings, a recent case report indicates that IL-1 activity produced by monocytes from two children with Haemophilus influenza meningitis upon LPS stimulation was significantly reduced (66) . On the contrary Fieren et al. (67) reported that peritoneal macrophages from patients on continuous ambulatory peritoneal dialysis with infectious peritonitis, had an increased IL-I3 release upon in vitro challenge with LPS. In this study, only one of eight patients had a gramnegative infection.
Interestingly, the observed down production of cytokine production upon LPS stimulation was a transient event in survival patients. At the end ofthe survey, they recovered levels of in vitro cytokine productions close to those ofhealthy controls. Although this finding was expected, it ensured that despite a well-known interindividual heterogeneity in cytokine production, comparison could be made between groups.
The mechanisms underlying these phenomena remain to be fully elucidated and further experiments should address the question whether this dysregulation is a transcriptional or a posttranscriptional event, as shown in the rabbit model (68) . Different parameters can be suggested to explain this dysregulation. Stress is known to generate a decrease immune responsiveness. However, we did not find any correlation between the severity scores and the levels of in vitro cytokine productions.
Differences were found in IL-1#, IL-6, and TNFa production between patients with sepsis syndrome and patients with noninfectious shock although they had rather similar severity scores. Furthermore, the reduced production was not predictive for the outcome (recovery or death). All patients received different drugs; although none was directly associated with the observed phenomenom, one cannot exclude that an association between some of them may modify the in vitro cytokine production. However, the recovery of normal levels of cytokine productions among survival patients was observed while patients were still receiving most ofthese drugs. The nutritional status is also a factor which could influence the in vitro cytokine production. However, infected and noninfected groups had rather similar nutritional status. Because the phenomenon was mainly associated with gram-negative infection, we can hypothesize that our observation might account for the welldescribed endotoxin tolerance (69) which is accompanied by a decreased LPS-induced TNFa production (68, 70, 71) . This is currently investigated using other stimuli than LPS to know whether this downregulation is specific for this activator. Indeed, Takayama et al. (72) , using gamma interferon and muramyl dipeptide as inducers, showed that patients with sepsis had a greater TNFa production, as compared to normal controls.
The presence of cell-associated cytokine in circulating monocytes and the down regulation observed upon a further in vitro activation suggest the existence of complex regulatory mechanisms, and further experiments are required to under- 
